Stay updated on 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.

Latest updates to the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA site-wide NIH notice about transitioning from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe footer revision identifier advances from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous study details, locations, and related content with an access notice. This reflects a shift from publicly viewable study information to an error page.SummaryDifference18%

- Check48 days agoChange DetectedThe page's revision label was updated to v3.7.0, indicating a site software update. This change does not modify the displayed trial details.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page footer revision label was updated from v3.6.5 to v3.6.6, indicating a small maintenance update.SummaryDifference0.0%

- Check84 days agoChange DetectedA new page revision label was issued, updating from v3.6.4 to v3.6.5. This appears to reflect an infrastructure or template update on the site and does not alter study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.